Proton pump inhibitor therapy predisposes to community‐acquired <i><scp>S</scp>treptococcus pneumoniae</i> pneumonia

Abstract

Proton pump inhibitor therapy was associated with an approximately 2-fold increased risk to develop community-acquired pneumonia possibly as a result of S. pneumoniae infection.